GUNA-ALLERGY-PREV

Active substance: AMBROSIA ARTEMISIIFOLIA, ARUNDO PLINIANA ROOT, ASCLEPIAS CURASSAVICA, BLACK CURRANT, CITRIC ACID MONOHYDRATE, HISTAMINE DIHYDROCHLORIDE, INTERFERON GAMMA-1B, HUMAN INTERLEUKIN 12, MANGANESE GLUCONATE, SODIUM PYRUVATE, SODIUM SULFATE, PARIETARIA OFFICINALIS, PHLEUM PRATENSE, ANGUILLA ROSTRATA BLOOD SERUM, SUCCINIC ACID, SULFUR, URTICA URENS, VIBURNUM OPULUS ROOT, WYETHIA HELENIOIDES ROOT

SOLUTION/ DROPS · AMBROSIA ARTEMISIIFOLIA 18 [hp_X]/30mL, ARUNDO PLINIANA ROOT 18 [hp_X]/30mL, ASCLEPIAS CURASSAVICA 6 [hp_X]/30mL, BLACK CURRANT 1 [hp_X]/30mL, CITRIC ACID MONOHYDRATE 6 [hp_X]/30mL, HISTAMINE DIHYDROCHLORIDE 30 [hp_X]/30mL, INTERFERON GAMMA-1B 4 [hp_C]/30mL, HUMAN INTERLEUKIN 12 4 [hp_C]/30mL, MANGANESE GLUCONATE 4 [hp_X]/30mL, SODIUM PYRUVATE 6 [hp_X]/30mL, SODIUM SULFATE 200 [hp_X]/30mL, PARIETARIA OFFICINALIS 18 [hp_X]/30mL, PHLEUM PRATENSE 18 [hp_X]/30mL, ANGUILLA ROSTRATA BLOOD SERUM 200 [hp_X]/30mL, SUCCINIC ACID 6 [hp_X]/30mL, SULFUR 30 [hp_X]/30mL, URTICA URENS 18 [hp_X]/30mL, VIBURNUM OPULUS ROOT 3 g/30mL, WYETHIA HELENIOIDES ROOT 18 [hp_X]/30mL

United StatesActive

Marketing holder: Guna spa

Verified 2026-10-09 · openFDA NDC

Analogues in other countries

Source: openFDA NDC
Countries with the substance registered: 2

Composition

AMBROSIA ARTEMISIIFOLIA · 18 [hp_X]/30mL
ARUNDO PLINIANA ROOT · 18 [hp_X]/30mL
ASCLEPIAS CURASSAVICA · 6 [hp_X]/30mL
BLACK CURRANT · 1 [hp_X]/30mL
CITRIC ACID MONOHYDRATE · 6 [hp_X]/30mL
HISTAMINE DIHYDROCHLORIDE · 30 [hp_X]/30mL
INTERFERON GAMMA-1B · 4 [hp_C]/30mL
HUMAN INTERLEUKIN 12 · 4 [hp_C]/30mL
MANGANESE GLUCONATE · 4 [hp_X]/30mL
SODIUM PYRUVATE · 6 [hp_X]/30mL
SODIUM SULFATE · 200 [hp_X]/30mL
PARIETARIA OFFICINALIS · 18 [hp_X]/30mL
PHLEUM PRATENSE · 18 [hp_X]/30mL
ANGUILLA ROSTRATA BLOOD SERUM · 200 [hp_X]/30mL
SUCCINIC ACID · 6 [hp_X]/30mL
SULFUR · 30 [hp_X]/30mL
URTICA URENS · 18 [hp_X]/30mL
VIBURNUM OPULUS ROOT · 3 g/30mL
WYETHIA HELENIOIDES ROOT · 18 [hp_X]/30mL

Products containing citric acid in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

Country	Products
RU 15	Алка-Зельтцер® таблетки шипучие, 324 мг+965 мг+1625 мг (original in Russian, GRLS) ЛП-№(016068)-(РГ-RU) АО "Байер" Алка-Зельтцер® таблетки шипучие, 324 мг+965 мг+1625 мг (original in Russian, GRLS) П N014962/01 АО "Байер" Блемарен® таблетки шипучие, ~ (original in Russian, GRLS) ЛП-№(000446)-(РГ-RU) Аристо Фарма ГмбХ Блемарен® таблетки шипучие, ~ (original in Russian, GRLS) ЛСР-001331/07 Эспарма ГмбХ Лимонной кислоты моногидрат субстанция-порошок, ~, 25 кг (original in Russian, GRLS) ФС-001765 Общество с ограниченной ответственностью "Медицинский научно-производственный комплекс "БИОТИКИ" (ООО "МНПК "БИОТИКИ") All products in this country (15)

Country

Products

RU 15

Алка-Зельтцер®
таблетки шипучие, 324 мг+965 мг+1625 мг (original in Russian, GRLS)
ЛП-№(016068)-(РГ-RU)
АО "Байер"
Алка-Зельтцер®
таблетки шипучие, 324 мг+965 мг+1625 мг (original in Russian, GRLS)
П N014962/01
АО "Байер"
Блемарен®
таблетки шипучие, ~ (original in Russian, GRLS)
ЛП-№(000446)-(РГ-RU)
Аристо Фарма ГмбХ
Блемарен®
таблетки шипучие, ~ (original in Russian, GRLS)
ЛСР-001331/07
Эспарма ГмбХ
Лимонной кислоты моногидрат
субстанция-порошок, ~, 25 кг (original in Russian, GRLS)
ФС-001765
Общество с ограниченной ответственностью "Медицинский научно-производственный комплекс "БИОТИКИ" (ООО "МНПК "БИОТИКИ")

All products in this country (15)

Registration

Registration number: 17089-299
Registration status: Active
Dispensing: Over the counter
Route: ORAL

Sources

product · openFDA NDC · 17089-299 · Verified 2026-10-09 · open in source
registration_status · openFDA NDC · 17089-299 · Verified 2026-10-09 · open in source
ingredients.0 · openFDA NDC · 17089-299 · Verified 2026-10-09 · open in source
ingredients.1 · openFDA NDC · 17089-299 · Verified 2026-10-09 · open in source
ingredients.2 · openFDA NDC · 17089-299 · Verified 2026-10-09 · open in source
ingredients.3 · openFDA NDC · 17089-299 · Verified 2026-10-09 · open in source
ingredients.4 · openFDA NDC · 17089-299 · Verified 2026-10-09 · open in source
ingredients.5 · openFDA NDC · 17089-299 · Verified 2026-10-09 · open in source
ingredients.6 · openFDA NDC · 17089-299 · Verified 2026-10-09 · open in source
ingredients.7 · openFDA NDC · 17089-299 · Verified 2026-10-09 · open in source
ingredients.8 · openFDA NDC · 17089-299 · Verified 2026-10-09 · open in source
ingredients.9 · openFDA NDC · 17089-299 · Verified 2026-10-09 · open in source
ingredients.10 · openFDA NDC · 17089-299 · Verified 2026-10-09 · open in source
ingredients.11 · openFDA NDC · 17089-299 · Verified 2026-10-09 · open in source
ingredients.12 · openFDA NDC · 17089-299 · Verified 2026-10-09 · open in source
ingredients.13 · openFDA NDC · 17089-299 · Verified 2026-10-09 · open in source
ingredients.14 · openFDA NDC · 17089-299 · Verified 2026-10-09 · open in source
ingredients.15 · openFDA NDC · 17089-299 · Verified 2026-10-09 · open in source
ingredients.16 · openFDA NDC · 17089-299 · Verified 2026-10-09 · open in source
ingredients.17 · openFDA NDC · 17089-299 · Verified 2026-10-09 · open in source
ingredients.18 · openFDA NDC · 17089-299 · Verified 2026-10-09 · open in source